After gaining resounding creditor support, Purdue Pharma's settlement plan now needs to secure court approval.

All 50 states as well as Washington, D.C., and four U.S. territories have agreed to sign a $7.4 billion settlement with the company and once-prominent family behind OxyContin, officials announced ...

(Bloomberg) -- Creditors of Purdue Pharma voted in favor of the opioid maker’s proposal to exit bankruptcy and pay billions to communities and individuals who say they were harmed by the company’s ...

Purdue Pharma LP agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin, ...

Two members of the wealthy Sackler family who own OxyContin maker Purdue Pharma LP offered apologies on Thursday for the role the prescription painkiller has played in the deadly U.S. opioid epidemic ...

The city is set to receive $48 million from a settlement with Purdue Pharma and its former owners, the Sackler family, for their role in producing and marketing highly addictive opioids. Mayor Eric ...

Cities through the county are joining more settlement agreements with a number of pharmaceutical companies involved in the opioid crisis, including Purdue Pharma, Alvogen and Indivior. Over the last ...

The loophole, bill sponsors said, arose from a law excluding money from individuals involved in opioid settlements being directed to the Opioid Settlement Fund, as it only pertained to manufacturers, ...

STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma L.P. (“Purdue”) today announced that its Chapter 11 Plan of Reorganization (“Plan”) received support from more than 99% of voting creditors, based on ...

The $7.4 billion settlement plan proposed by OxyContin maker Purdue Pharma and the Sackler family members who own the bankrupt firm has gained nearly unanimous creditor approval. More than 54,000 ...